OnKure Therapeutics, Inc.
OKUR
$2.60
-$0.02-0.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 15.40M | 13.21M | 13.09M | 10.37M | 7.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.68M | 62.69M | 60.09M | 52.92M | 44.96M |
| Operating Income | -66.68M | -62.69M | -60.09M | -52.92M | -44.96M |
| Income Before Tax | -63.46M | -60.31M | -59.06M | -52.67M | -44.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -63.46 | -60.31 | -59.06 | -52.67 | -44.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.46M | -60.31M | -59.06M | -52.67M | -44.69M |
| EBIT | -66.68M | -62.69M | -60.09M | -52.92M | -44.96M |
| EBITDA | -66.22M | -62.22M | -59.62M | -52.46M | -44.50M |
| EPS Basic | -4.78 | -40.24 | -83.92 | -113.10 | -112.45 |
| Normalized Basic EPS | -2.94 | -25.11 | -51.17 | -69.41 | -69.05 |
| EPS Diluted | -4.78 | -40.24 | -83.92 | -113.10 | -112.45 |
| Normalized Diluted EPS | -2.94 | -25.11 | -51.17 | -69.41 | -69.05 |
| Average Basic Shares Outstanding | 53.24M | 40.02M | 26.83M | 13.72M | 14.28M |
| Average Diluted Shares Outstanding | 53.24M | 40.02M | 26.83M | 13.72M | 14.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |